the aid library

LIST OPTIONS

Filter

9158

Download (1323)

View PDF (1099)

The Haiti Health Sector Directory: U.S.-Based Implementers Working in Haiti

USAID, Synergie Project (2003) C1

Download (357)

View PDF (471)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (298)

View PDF (238)

Manuel de Géstion à l'usage des gestionnaires de médicaments et des membres des Comités de Gestion

Pharmacient sans Frontières Ministère de la Santé; Direction des Pharmacies et du Médicament; République du Bénin (2016) C2

Gestion de la Pharmacie dans les Centres de Santé au niveau périphérique

Download (511)

View PDF (1150)

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO) (2018) C_WHO

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t... more

Download (178)

View PDF (182)

Interim Infection Prevention and Control Recommendations for Coronavirus Disease 2019 (COVID-19) in Health Care Settings

Ministry of Health, Kenya (2020) C2

Accessed: 02.05.2020 These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu... more

Download (639)

View PDF (572)

Infant and young child feeding counselling: an integrated course: participant's manual
recommended

World Health Organization WHO; UNICEF (2021) C_WHO

The Participant’s manual contains summaries of information presented by the trainers, copies of worksheets and checklists for the clinical practice and practical sessions, and exercises that participants will do during the course. One manual should be provided for each participant, using the modul... more

Download (294)

View PDF (342)

Comparative Study of Pharmaceutical Waste Disposal in Ethiopia, Kenya, Sudan and Uganda

Iosue, S. PSA Tansforming The Supply Chain (2020) C1

Download (239)

View PDF (307)

Climate change-induced migration: a bibliometric review

García, J.M.; Caparrós-Martínez J.L., Rueda-López N., et al. (2021) CC

Globalization and Health (2021) 17:74 https://doi.org/10.1186/s12992-021-00722-3

Download (194)

View PDF (232)

Lobbying for Political Change under Adverse Political Conditions: Lessons from Advocacy Work in North Carolina

L. Storrow; D. Rowan AIDS 2016 (Durban South Africa); UNC Charlotte; NC AIDS Action Network (Education, Advocacy, Community) (2019) C2

Presented at the 21st international AIDS conference - Durban, South Africa Accessed: 17.11.2019

Download (197)

View PDF (196)

IOM Somalia Preparedness and Response Plan - COVID-19

OCHA; Reliefweb; IOM UN Migration IOM Somalia OCHA; Reliefweb; IOM UN Migration IOM Somalia (2020) C2

April 2020

Download (2305)

View PDF (2590)

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

World Health Organization WHO WHO (2012) C_WHO

Guidance for health workers

Download (841)

View PDF (1326)

Chart booklet - Guidelines for an Integrated Approach to the Nutritional care of HIV-infected children (6 months-14 years)

World Health Organization WHO (2009) C_WHO

The content of these guidelines acknowledges that wasting and undernutrition in HIV-infected children reflect a series of failures within the health system, the home and community and not just a biological process related to virus and host interactions. The guidelines do not cover the feeding of i... more

Download (548)

View PDF (877)

Security Facts for Humanitarian Aid Agencies: Comparing Urban and Rural Security Incidents

Christina Wille & Larissa Fast InsecurityInsight (2010) C2

How do security events affecting humanitarian agencies differ between urban and rural environments?

Download (814)

View PDF (1359)

Zika Virus Research Agenda - October 2016

World Health Organization WHO (2016) C_WHO

External Link

Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen

R. Diel, B. Hauer, R. Loddenkemper, et al. (2009) C2

Recommendations for Tuberculosis Screening Before Initiation of TNF-α-Inhibitor Treatment in Rheumatic Diseases Diel R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren… Pneumologie 2009; 63: 329–334

Download (799)

View PDF (543)

Compilation of community-based rehabilitation practices in the WHO South-East Asia Region

World Health Organization WHO, Regional Office for South East Asia (2013) C_WHO

Download (265)

View PDF (337)

Towards disability - inclusive education

Saeboenes, A.-M.; et al. Expert Group on Disability (2015) CC

Background paper for the Oslo Summit on Education for Development. This paper covers the four topics of the Oslo Summit: investment in education, quality of learning, education in emergencies and girls’ education. Disability continues to be one of the primary causes of educational disadvantage a... more